All posts tagged enzalutamide

  • Jennifer Richer

    Phase 1 results point to larger trial of enzalutamide and fulvestrant in advanced breast cancer

    Jennifer Richer, PhD, and colleagues report promising results of a phase 1 clinical trial of combination enzalutamide and fulvestrant against advanced breast cancer.

Overwhelming evidence adds a major new target in breast cancer: androgens including testosterone. Image: Flickr/khrawlings
Breast.Cancer.Pink
Flickr: Wolfram Burner
Jennifer Richer
Overwhelming evidence adds a major new target in breast cancer: androgens including testosterone. Image: Flickr/khrawlings
An aging population requires new approaches to prostate cancer care. Image: Flickr/PaulineMak
Like a burr, cancer cells wave receptors designed to trap things they need -- researchers hope that blocking the androgen receptors of AR+ breast cancer cells will stop the signals of growth. Image: Flickr/gomagoti
Harry Peterson, CU Cancer Center